Free Trial
→ 7 Stocks Set to Win Big Under Trump’s America First Agenda 🚀 (From TradingTips) (Ad) Buy NLSP Stock  Free NLSP Stock Alerts

NLS Pharmaceutics (NLSP) SEC Filings & 10K Form

NLS Pharmaceutics logo
$1.30 -0.23 (-15.03%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$1.42 +0.12 (+9.23%)
As of 03/28/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/10/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:52 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
12/03/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This trading frustration almost made me quit (Ad)

This happened to me time and time again, and I wanted no more of it. That’s exactly why I set out to refine my strategy… And with the help of my good friend Nate, we have done exactly that… Now, I cannot promise future returns or against losses, but the real trades so far have been nothing but astounding. Turning my once 69% win rate, into 83.3% on real trades in the last two months. And instead of just telling you, I want to SHOW you.

And you can check it out right here.
11/05/2024
3:30 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
8:16 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
07/01/2024
7:26 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 424B5
07/01/2024
7:09 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
3:54 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
11:15 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form EFFECT
06/25/2024
3:31 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
8:28 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
8:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
4:25 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
8:10 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
4:16 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
3:11 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSP) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Just Revealed: The chip company making AI look primitive
In his just-released video presentation, this renowned market strategist — who's been called "one of the most ...
InvestorPlace | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
Urgent Bitcoin alert for RIGHT NOW
Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...
Brownstone Research | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored